Avalon Globocare (FRA:2XJ0) FCF Margin % : -248.30% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Avalon Globocare FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avalon Globocare's Free Cash Flow for the three months ended in Dec. 2023 was €-0.73 Mil. Avalon Globocare's Revenue for the three months ended in Dec. 2023 was €0.29 Mil. Therefore, Avalon Globocare's FCF Margin % for the quarter that ended in Dec. 2023 was -248.30%.

As of today, Avalon Globocare's current FCF Yield % is -216.63%.

The historical rank and industry rank for Avalon Globocare's FCF Margin % or its related term are showing as below:

FRA:2XJ0' s FCF Margin % Range Over the Past 10 Years
Min: -1334.28 Med: -422.41 Max: -111.36
Current: -521.07

During the past 10 years, the highest FCF Margin % of Avalon Globocare was -111.36%. The lowest was -1334.28%. And the median was -422.41%.

FRA:2XJ0's FCF Margin % is ranked worse than
97.55% of 1797 companies
in the Real Estate industry
Industry Median: 4.96 vs FRA:2XJ0: -521.07

Avalon Globocare FCF Margin % Historical Data

The historical data trend for Avalon Globocare's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare FCF Margin % Chart

Avalon Globocare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-482.46

-547.48

-362.47

-1,333.92

-519.53

Avalon Globocare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-664.52	-627.90	-824.38	-407.74	-248.30

Competitive Comparison of Avalon Globocare's FCF Margin %

For the Real Estate Services subindustry, Avalon Globocare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avalon Globocare's FCF Margin % Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's FCF Margin % falls into.

Avalon Globocare FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avalon Globocare's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-5.985	/	1.152
	=	-519.53 %

Avalon Globocare's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.73	/	0.294
	=	-248.30 %

Avalon Globocare FCF Margin % Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avalon Globocare (FRA:2XJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (FRA:2XJ0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ALBT:USA

Address

4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728

Website

https://www.avalon-globocare.com

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare (FRA:2XJ0) Headlines

No Headlines